Primary brain tumours in adults

D Ricard, A Idbaih, F Ducray, M Lahutte… - The Lancet, 2012 - thelancet.com
Important advances have been made in the understanding and management of adult
gliomas and primary CNS lymphomas—the two most common primary brain tumours …

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

MJ van den Bent, JS Wefel, D Schiff… - The lancet …, 2011 - thelancet.com
Although low-grade gliomas (LGG) have a less aggressive course than do high-grade
gliomas, the outcome of these tumours is ultimately fatal in most patients. Both the tumour …

An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas

G Li, L Li, Y Li, Z Qian, F Wu, Y He, H Jiang, R Li… - Brain, 2022 - academic.oup.com
Preoperative MRI is one of the most important clinical results for the diagnosis and treatment
of glioma patients. The objective of this study was to construct a stable and validatable …

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

BG Baumert, ME Hegi, MJ van den Bent… - The Lancet …, 2016 - thelancet.com
Background Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting
molecular heterogeneity of the disease. We compared two different, single-modality …

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases

L Capelle, D Fontaine, E Mandonnet… - Journal of …, 2013 - thejns.org
Object The spontaneous prognostic factors and optimal therapeutic strategy for WHO Grade
II gliomas (GIIGs) have yet to be unanimously defined. Specifically, the role of resection is …

New concepts in the management of diffuse low-grade glioma: proposal of a multistage and individualized therapeutic approach

H Duffau, L Taillandier - Neuro-oncology, 2015 - academic.oup.com
Diffuse low-grade glioma grows, migrates along white matter tracts, and progresses to high-
grade glioma. Rather than a “wait and see” policy, an aggressive attitude is now …

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

C Houillier, X Wang, G Kaloshi, K Mokhtari… - Neurology, 2010 - AAN Enterprises
Objectives: Recent studies have shown that IDH1 and IDH2 mutations occur frequently in
gliomas, including low-grade gliomas. However, their impact on the prognosis and …

Temozolomide-associated hypermutation in gliomas

S Choi, Y Yu, MR Grimmer, M Wahl, SM Chang… - Neuro …, 2018 - academic.oup.com
Low-grade gliomas cause considerable morbidity and most will recur after initial therapy. At
recurrence, low-grade gliomas can undergo transformation to high-grade gliomas (grade III …

[HTML][HTML] A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas

X Liu, Y Li, Z Qian, Z Sun, K Xu, K Wang, S Liu… - NeuroImage: Clinical, 2018 - Elsevier
Objective The aim of this study was to develop a radiomics signature for prediction of
progression-free survival (PFS) in lower-grade gliomas and to investigate the genetic …

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice

M Weller, R Stupp, ME Hegi, M Van Den Bent… - Neuro …, 2012 - academic.oup.com
Histological subtyping and grading by malignancy are the cornerstones of the World Health
Organization (WHO) classification of tumors of the central nervous system. They shall …